Table Of Contents: AHFS Pharmacologic-Therapeutic Classification 0:01 Front Matter 4:00 Antihistamine Drugs 4:04 First Generation Antihistamines
|
|
|
- Virgil Oliver
- 5 years ago
- Views:
Transcription
1 Table Of Contents: AHFS Pharmacologic-Therapeutic Classification 0:01 Front Matter 4:00 Antihistamine Drugs 4:04 First Generation Antihistamines 4:04.04 Ethanolamine Derivatives 4:04.08 Ethylenediamine Derivatives 4:04.12 Phenothiazine Derivatives 4:04.16 Piperazine Derivatives 4:04.20 Propylamine Derivatives 4:04.92 Miscellaneous Derivatives 4:08 Second Generation Antihistamines 4:92 Other Antihistamines 8:00 Anti-infective Agents 8:08 Anthelmintics 8:12 Antibacterials 8:12.02 Aminoglycosides 8:12.06 Cephalosporins 8: First Generation Cephalosporins 8: Second Generation Cephalosporins 8: Third Generation Cephalosporins 8: Fourth Generation Cephalosporins 8:12.07 Miscellaneous β-lactams
2 8: Carbacephems 8: Carbapenems 8: Cephamycins 8: Monobactams 8:12.08 Chloramphenicol 8:12.12 Macrolides 8: Erythromycins 8: Ketolides 8: Other Macrolides 8:12.16 Penicillins 8: Natural Penicillins 8: Aminopenicillins 8: Penicillinase-resistant Penicillins 8: Extended-spectrum Penicillins 8:12.18 Quinolones 8:12.20 Sulfonamides 8:12.24 Tetracyclines 8: Glycylcyclines 8:12.28 Antibacterials, Miscellaneous 8: Aminocyclitols 8: Bacitracins 8: Cyclic Lipopeptides 8: Glycopeptides 8: Lincomyeins 8: Oxazolidinones 8: Polymyxins 8: Rifamycins 8: Streptogramins 8: Other Miscellaneous Antibacterials 8:14 Antifungals 8:14.04 Allylamines 8:14.08 Azoles 8:14.16 Echinocandins 8:14.28 Polyenes 8:14.32 Pyrimidines 8:14.92 Antifungals, Miscellaneous
3 8:16 Antimycobacterials 8:16.04 Antituberculosis Agents 8:16.92 Antimycobacterials, Miscellaneous 8:18 Antivirals 8:18.04 Adamantanes 8:18.08 Antiretrovirals 8: HIV Fusion Inhibitors 8: HIV Protease Inhibitors 8: Integrase Inhibitors 8: Nonnucleoside Reverse Transcriptase Inhibitors 8: Nucleoside and Nucleotide Reverse Transcriptase Inhibitors 8: Antiretrovirals, Miscellaneous 8:18.20 Interferons 8:18.24 Monoclonal Antibodies 8:18.28 Neuraminidase Inhibitors 8:18.32 Nucleosides and Nucleotides 8:18.92 Antivirals, Miscellaneous 8:30 Antiprotozoals 8:30.04 Amebicides 8:30.08 Antimalarials 8:30.92 Antiprotozoals, Miscellaneous 8:36 Urinary Anti-infectives 8:92 Anti-infectives, Miscellaneous 10:00 Antineoplastic Agents 12:00 Autonomic Drugs 12:04 Parasympathomimetic (Cholinergic) Agents 12:08 Anticholinergic Agents 12:08.04 Antiparkinsonian Agents 12:08.08 Antimuscarinics/Antispasmodics 12:12 Sympathomimetic (Adrenergic) Agents 12:12.04 α-adrenergic Agonists 12:12.08 β-adrenergic Agonists 12: Non-selective β-adrenergic Agonists 12: Selective β1-adrenergic Agonists 12: Selective β2-adrenergic Agonists 12:12.12 α- and β-adrenergic Agonists
4 12:16 Sympatholytic (Adrenergic Blocking) Agents 12:16.04 α-adrenergic Blocking Agents 12: Non-selective α-adrenergic Blocking Agents 12: Non-selective α1-adrenergic Blocking Agents 12: Selective α1-adrenergic Blocking Agents 12:16.08 β-adrenergic Blocking Agents 12: Non-selective β-adrenergic Blocking Agents 12: Selective β-adrenergic Blocking Agents 12:20 Skeletal Muscle Relaxants 12:20.04 Centrally Acting Skeletal Muscle Relaxants 12:20.08 Direct-acting Skeletal Muscle Relaxants 12:20.12 GABA-derivative Skeletal Muscle Relaxants 12:20.20 Neuromuscular Blocking Agents 12:20.92 Skeletal Muscle Relaxants, Miscellaneous 12:92 Autonomic Drugs, Miscellaneous 16:00 Blood Derivatives 20:00 Blood Formation, Coagulation, and Thrombosis 20:04 Antianemia Drugs 20:04.04 Iron Preparations 20:04.08 Liver and Stomach Preparations 20:12 Antithrombotic Agents 20:12.04 Anticoagulants 20: Coumarin Derivatives 20: Direct Thrombin Inhibitors 20: Heparins 20: Anticoagulants, Miscellaneous 20:12.14 Platelet-reducing Agents 20:12.18 Platelet-aggregation Inhibitors 20:12.20 Thrombolytic Agents 20:16 Hematopoietic Agents 20:24 Hemorrheologic Agents 20:28 Antihemorrhagic Agents 20:28.08 Antiheparin Agents 20:28.16 Hemostatics 24:00 Cardiovascular Drugs 24:04 Cardiac Drugs
5 24:04.04 Antiarrhythmic Agents 24: Class Ia Antiarrhythmics 24: Class Ib Antiarrhythmics 24: Class Ic Antiarrhythmics 24: Class II Antiarrhythmics 24: Class III Antiarrhythmics 24: Class IV Antiarrhythmics 24: Antiarrhythmics, Miscellaneous 24:04.08 Cardiotonic Agents 24:04.92 Cardiac Drugs, Miscellaneous 24:06 Antilipemic Agents 24:06.04 Bile Acid Sequestrants 24:06.05 Cholesterol Absorption Inhibitors 24:06.06 Fibric Acid Derivatives 24:06.08 HMG-CoA Reductase Inhibitors 24:06.92 Antilipemic Agents, Miscellaneous 24:08 Hypotensive Agents 24:08.04 α-adrenergic Blocking Agents 24:08.08 β-adrenergic Blocking Agents 24:08.12 Calcium-Channel Blocking Agents 24: Dihydropyridines 24: Calcium-Channel Blocking Agents, Miscellaneous 24:08.16 Central α-agonists 24:08.20 Direct Vasodilators 24:08.24 Diuretics 24: Carbonic Anhydrase Inhibitors 24: Loop Diuretics 24: Osmotic Diuretics 24: Potassium-sparing Diuretics 24: Thiazide Diuretics 24: Thiazide-like Diuretics 24: Diuretics, Miscellaneous 24:08.32 Peripheral Adrenergic Inhibitors 24:08.44 Renin-Angiotensin-Aldosterone System Inhibitors 24: Angiotensin-Converting Enzyme Inhibitors 24: Angiotensin II Receptor Antagonists
6 24: Mineralocorticoid (Aldosterone) Receptor Antagonists 24:08.92 Hypotensive Agents, Miscellaneous 24:12 Vasodilating Agents 24:12.08 Nitrates and Nitrites 24:12.12 Phosphodiesterase Inhibitors 24:12.92 Vasodilating Agents, Miscellaneous 24:16 Sclerosing Agents 24:20 α-adrenergic Blocking Agents 24:24 β-adrenergic Blocking Agents 24:28 Calcium-Channel Blocking Agents 24:28.08 Dihydropyridines 24:28.92 Calcium-Channel Blocking Agents, Miscellaneous 24:32 Renin-Angiotensin-Aldosterone System Inhibitors 24:32.04 Angiotensin-Converting Enzyme Inhibitors 24:32.08 Angiotensin II Receptor Antagonists 24:32.20 Mineralocorticoid (Aldosterone) Receptor Antagonists 24:32.40 Renin Inhibitors 26:00 Cellular Therapy 28:00 Central Nervous System Agents 28:04 General Anesthetics 28:04.04 Barbiturates 28:04.16 Inhalation Anesthetics 28:04.92 General Anesthetics, Miscellaneous 28:08 Analgesics and Antipyretics 28:08.04 Nonsteroidal Anti-inflammatory Agents 28: Cyclooxygenase-2 (COX-2) Inhibitors 28: Salicylates 28: Other Nonsteroidal Anti-inflammatory Agents 28:08.08 Opiate Agonists 28:08.12 Opiate Partial Agonists 28:08.92 Analgesics and Antipyretics, Miscellaneous 28:10 Opiate Antagonists 28:12 Anticonvulsants 28:12.04 Barbiturates 28:12.08 Benzodiazepines 28:12.12 Hydantoins
7 28:12.16 Oxazolidinediones 28:12.20 Succinimides 28:12.92 Anticonvulsants, Miscellaneous 28:16 Psychotherapeutic Agents 28:16.04 Antidepressants 28: Monoamine Oxidase Inhibitors 28: Selective Serotonin- and Norepinephrine-reuptake Inhibitors 28: Selective-serotonin Reuptake Inhibitors 28: Serotonin Modulators 28: Tricyclics and Other Norepinephrine-reuptake Inhibitors 28: Antidepressants, Miscellaneous 28:16.08 Antipsychotics 28: Atypical Antipsychotics 28: Butyrophenones 28: Phenothiazines 28: Thioxanthenes 28: Antipsychotics, Miscellaneous 28:16.92 Psychotherapeutic Agents, Miscellaneous 28:20 Anorexigenic Agents and Respiratory and Cerebral Stimulants 28:20.04 Amphetamines 28:20.92 Anorexigenic Agents and Respiratory and Cerebral Stimulants, Miscellaneous 28:24 Anxiolytics, Sedatives, and Hypnotics 28:24.04 Barbiturates 28:24.08 Benzodiazepines 28:24.92 Anxiolytics, Sedatives, and Hypnotics: Miscellaneous 28:28 Antimanic Agents 28:32 Antimigraine Agents 28:32.28 Selective Serotonin Agonists 28:32.92 Antimigraine Agents, Miscellaneous 28:36 Antiparkinsonian Agents 28:36.04 Adamantanes 28:36.08 Anticholinergic Agents 28:36.12 Catechol-O-Methyltransferase (COMT) Inhibitors 28:36.16 Dopamine Precursors 28:36.20 Dopamine Receptor Agonists 28: Ergot-derivative Dopamine Receptor Agonists
8 28: Nonergot-derivative Dopamine Receptor Agonists 28:36.32 Monoamine Oxidase B Inhibitors 28:40 Fibromyalgia Agents 28:92 Central Nervous System Agents, Miscellaneous 32:00 Contraceptives (foams, devices) 34:00 Dental Agents 36:00 Diagnostic Agents 36:04 Adrenocortical Insufficiency 36:08 Amyloidosis 36:10 Appendicitis 36:12 Blood Volume 36:16 Brucellosis 36:18 Cardiac Function 36:24 Circulation Time 36:26 Diabetes Mellitus 36:28 Diphtheria 36:30 Drug Hypersensitivity 36:32 Fungi 36:34 Gallbladder Function 36:36 Gastric Function 36:38 Intestinal Absorption 36:40 Kidney Function 36:44 Liver Function 36:48 Lymphogranuloma Venereum 36:52 Mumps 36:56 Myasthenia Gravis 36:58 Ocular Disorders 36:60 Thyroid Function 36:61 Pancreatic Function 36:62 Phenylketonuria 36:64 Pheochromocytoma 36:66 Pituitary Function 36:68 Roentgenography 36:72 Scarlet Fever 36:76 Sweating 36:80 Trichinosis
9 36:84 Tuberculosis 36:88 Urine and Feces Contents 36:88.12 Ketones 36:88.20 Occult Blood 36:88.24 ph 36:88.28 Protein 36:88.40 Sugar 38:00 Disinfectants (for agents used on objects other than skin) 40:00 Electrolytic, Caloric, and Water Balance 40:04 Acidifying Agents 40:08 Alkalinizing Agents 40:10 Ammonia Detoxicants 40:12 Replacement Preparations 40:18 Ion-removing Agents 40:18.16 Sodium-removing Agents 40:18.17 Calcium-removing Agents 40:18.18 Potassium-removing Agents 40:18.19 Phosphate-removing Agents 40:18.92 Other Ion-removing Agents 40:20 Caloric Agents 40:24 Salt and Sugar Substitutes 40:28 Diuretics 40:28.04 Carbonic Anhydrase Inhibitors 40:28.08 Loop Diuretics 40:28.12 Osmotic Diuretics 40:28.16 Potassium-sparing Diuretics 40:28.20 Thiazide Diuretics 40:28.24 Thiazide-like Diuretics 40:28.28 Vasopressin Antagonists 40:28.92 Diuretics, Miscellaneous 40:36 Irrigating Solutions 40:40 Uricosuric Agents 44:00 Enzymes 48:00 Respiratory Tract Agents 48:04 Antihistamines 48:04.04 First Generation Antihistamines
10 48:04.08 Second Generation Antihistamines 48:08 Antitussives 48:10 Anti-inflammatory Agents 48:10.08 Corticosteroids 48: Nasal Preparations 48: Orally Inhaled Preparations 48:10.24 Leukotriene Modifiers 48:10.32 Mast-cell Stabilizers 48:12 Bronchodilators 48:12.04 Adrenergic Agents 48: Non-selective β-adrenergic Agonists 48: Selective β2-adrenergic Agonists 48: α- and β-adrenergic Agonists 48:12.08 Anticholinergic Agents 48:12.12 Xanthine Derivatives 48:16 Expectorants 48:24 Mucolytic Agents 48:36 Pulmonary Surfactants 48:48 Vasodilating Agents 48:92 Respiratory Agents, Miscellaneous 52:00 Eye, Ear, Nose, and Throat (EENT) Preparations 52:02 Antiallergic Agents 52:04 Anti-infectives 52:04.04 Antibacterial 52:04.16 Antifungals 52:04.20 Antivirals 52:04.92 Anti-infectives, Miscellaneous 52:08 Anti-inflammatory Agents 52:08.08 Corticosteroids 52:08.20 Nonsteroidal Anti-inflammatory Agents 52:08.92 Anti-inflammatory Agents, Miscellaneous 52:12 Contact Lens Solutions 52:16 Local Anesthetics 52:24 Mydriatics 52:28 Mouthwashes and Gargles 52:32 Vasoconstrictors
11 52:40 Antiglaucoma Agents 52:40.04 α-adrenergic Agonists 52:40.08 β-adrenergic Agents 52:40.12 Carbonic Anhydrase Inhibitors 52:40.20 Miotics 52:40.24 Osmotic Agents 52:40.28 Prostaglandin Analogs 52:40.92 Antiglaucoma Agents, Miscellaneous 52:92 EENT Drugs, Miscellaneous 56:00 Gastrointestinal Drugs 56:04 Antacids and Adsorbents 56:08 Antidiarrhea Agents 56:10 Antiflatulents 56:12 Cathartics and Laxatives 56:14 Cholelitholytic Agents 56:16 Digestants 56:20 Emetics 56:22 Antiemetics 56:22.08 Antihistamines 56: HT3 Receptor Antagonists 56:22.92 Antiemetics, Miscellaneous 56:24 Lipotropic Agents 56:28 Antiulcer Agents and Acid Suppressants 56:28.12 Histamine H2-Antagonists 56:28.28 Prostaglandins 56:28.32 Protectants 56:28.36 Proton-pump Inhibitors 56:32 Prokinetic Agents 56:36 Anti-inflammatory Agents 56:92 Gl Drugs, Miscellaneous 60:00 Gold Compounds 64:00 Heavy Metal Antagonists 68:00 Hormones and Synthetic Substitutes 68:04 Adrenals 68:08 Androgens 68:12 Contraceptives
12 68:16 Estrogens and Estrogen Agonist-Antagonists 68:16.04 Estrogens 68:16.12 Estrogen Agonist-Antagonists 68:18 Gonadotropins 68:20 Antidiabetic Agents 68:20.02 α-glucosidase Inhibitors 68:20.03 Amylinomimetics 68:20.04 Biguanides 68:20.05 Dipeptidyl Peptidase IV (DDP-4) Inhibitors 68:20.06 Incretin Mimetics 68:20.08 Insulins 68:20.16 Meglitinides 68:20.20 Sulfonylureas 68:20.28 Thiazolidinediones 68:20.92 Antidiabetic Agents, Miscellaneous 68:22 Antihypoglycemic Agents 68:22.12 Glycogenolytic Agents 68:22.92 Antihypoglycemic Agents, Miscellaneous 68:24 Parathyroid 68:28 Pituitary 68:30 Somatotropin Agonists and Antagonists 68:30.04 Somatotropin Agonists 68:30.08 Somatotropin Antagonists 68:32 Progestins 68:34 Other Corpus Luteum Hormones 68:36 Thyroid and Antithyroid Agents 68:36.04 Thyroid Agents 68:36.08 Antithyroid Agents 72:00 Local Anesthetics 76:00 Oxytocics 78:00 Radioactive Agents 80:00 Serums, Toxoids, and Vaccines 80:04 Serums 80:08 Toxoids 80:12 Vaccines 84:00 Skin and Mucous Membrane Agents
13 84:04 Anti-infectives 84:04.04 Antibacterials 84:04.06 Antivirals 84:04.08 Antifungals 84: Allylamines 84: Azoles 84: Benzylamines 84: Echinocandins 84: Hydroxypyridones 84: Polyenes 84: Pyrimidines 84: Thiocarbamates 84: Antifungals, Miscellaneous 84:04.12 Scabicides and Pediculicides 84:04.92 Local Anti-infectives, Miscellaneous 84:06 Anti-inflammatory Agents 84:08 Antipruritics and Local Anesthetics 84:12 Astringents 84:16 Cell Stimulants and Proliferants 84:20 Detergents 84:24 Emollients, Demulcents, and Protectants 84:24.04 Basic Lotions and Liniments 84:24.08 Basic Oils and Other Solvents 84:24.12 Basic Ointments and Protectants 84:24.16 Basic Powders and Demulcents 84:28 Keratolytic Agents 84:32 Keratoplastic Agents 84:50 Depigmenting and Pigmenting Agents 84:50.04 Depigmenting Agents 84:50.06 Pigmenting Agents 84:80 Sunscreen Agents 84:92 Skin and Mucous Membrane Agents, Miscellaneous 86:00 Smooth Muscle Relaxants 86:08 Gastrointestinal Smooth Muscle Relaxants 86:12 Genitourinary Smooth Muscle Relaxants 86:16 Respiratory Smooth Muscle Relaxants
14 88:00 Vitamins 88:04 Vitamin A 88:08 Vitamin B Complex 88:12 Vitamin C 88:16 Vitamin D 88:20 Vitamin E 88:24 Vitamin K Activity 88:28 Multivitamin Preparations 92:00 Miscellaneous Therapeutic Agents 92:04 Alcohol Deterrents 92:08 5-α-Reductase Inhibitors 92:12 Antidotes 92:16 Antigout Agents 92:20 Biologic Response Modifiers 92:24 Bone Resorption Inhibitors 92:28 Cariostatic Agents 92:32 Complement Inhibitors 92:36 Disease-Modifying Antirheumatic Agents 92:40 Gonadotropin-releasing Hormone Antagonists 92:44 Immunosuppressive Agents 92:56 Protective Agents 92:92 Other Miscellaneous Therapeutic Agents 94:00 Devices 96:00 Pharmaceutical Aids
2018 MEDICARE LOCAL COVERAGE DETERMINATION (LCD) - L34313 CPT CODES: 86003, ALLERGY TESTING
H10.411 Chronic giant papillary conjunctivitis, right eye H10.412 Chronic giant papillary conjunctivitis, left eye H10.413 Chronic giant papillary conjunctivitis, bilateral H10.45 Other chronic allergic
Drug Classifications
CLASSIFICATIONS: QUIZ 2 Drug Classifications 1. Which category of drugs is used to relieve minor to severe pain? a. Alkylates b. Analgesics c. Angiotensin-converting enzyme inhibitors d. Androgens e. Anesthetics
CONTENTS SECTION 1 SECTION
CONTENTS SECTION 1 Foundations of Drug Therapy 1 CHAPTER 1 Introduction to Pharmacology 3 A Message to Students 3 Pharmacology and Drug Therapy 3 Understanding Grouping and Naming of Drugs 4 Prescription
Drug Classifications
CLASSIFICATIONS: QUIZ 3 Drug Classifications 1. What category of drugs is used to lower lood pressure y converting an inactive enzyme to a potent vasoconstrictor? a. Alkylates. Analgesics c. Angiotensin-converting
Synthesis of Essential Drugs
-., f Synthesis of Essential Drugs R.vS. Vardanyan V.J. Hruby Dt pml»u nl nt Chcini\lr\ IMH> I I ~m\cr\it\ I /m. / M;\ ! \nroiui I in son. I S\ HiiEVIER Amsterdam - Boston - Heidelberg - London - New
FLORIDA 2017 EHB BENCHMARK PLAN
FLORIDA EHB BENCHMARK PLAN SUMMARY INFORMATION Plan Type Issuer Name Product Name Small Group Market Blue Cross and Blue Shield of Florida BlueOptions Plan Name BlueOptions Supplemented Categories (Supplementary
Pharmacology. An Introduction. Henry Hitner, Ph.D. Barbara Nagle, Ph.D. Learn. Neuroscience, Physiology,
Pharmacology An Introduction Henry Hitner, Ph.D. Department Neuroscience, Physiology, Philadelphia College of Osteopathie Medicine Philadelphia, Pennsylvania Adjunct Professor, Pharmacology Physician Assistant
Contents. SECTION 1 General Pharmacology. SECTION 2 Drugs Affecting Autonomic Nervous System
SECTION 1 General Pharmacology 1.1 Introduction and Terminology 3 Terminology 3; Nomenclature of Drugs 5; Sources of Drugs 5; Factors Affecting Dosage and Therapeutic Response 6; Effects of Drug Interactions
Table of Contents. 1. General Anesthetics. 1.1 Inhaled Anestethics 1.2 Noninhaled Anesthetics. 2. Local Anesthetics
Table of Contents 1. General Anesthetics 1.1 Inhaled Anestethics 1.2 Noninhaled Anesthetics 2. Local Anesthetics 2.1. Local Anesthetics of the Aminoether Series 2.2. Local Anesthetics of the Aminoamide
U.S. Census Bureau Pharmaceuticals, Except Biologicals MA325G(10) Issued July 2011
U.S. Census Bureau Pharmaceuticals, Except Biologicals - 2010 MA325G(10) Issued July 2011 Address inquiries concerning these data to Primary Goods Industries Branch, U.S. Department of Commerce, Census
Pharmacology. for Nursing Practice. Kathleen Gutierrez, PhD, RN, ANP, CNS
Pharmacology for Nursing Practice Kathleen Gutierrez, PhD, RN, ANP, CNS Adult Nurse Practitioner Private Practice; Associate Professor Regis University and University of Colorado Health Sciences Center
Medication Use in Older Adult Drivers: Findings from The AAA LongROAD Study
RESEARCH BRIEF Medication Use in Older Adult Drivers: Findings from The AAA LongROAD Study This research brief utilized data from the AAA Longitudinal Research on Aging Drivers (LongROAD) study to examine
Essentials for Medication Safety
ELSEVIER Essentials for Medication Safety M. Linda Workman, PhD, RN, FAAN Linda LaCharity, PhD, RN Susan C. Kruchko, MS, RN With Jennifer Ponto, RN, BSN Instructor Department of Vocational Nursing South
San Francisco Health Care Accountability Ordinance Minimum Standards Effective January 1, 2019
San Francisco Department of Public Health Barbara A. Garcia, MPA Director of Health City and County of San Francisco London N. Breed Mayor San Francisco Health Care Accountability Ordinance Standards Effective
Plan Change Alert. New Market Priced Drug (MPD) Program Effective 11/1/2016. Alaska United Food and Commercial Workers Trust
Plan Change Alert New Market Priced Drug (MPD) Program Effective 11/1/2016 Plan Sponsor Alaska United Food and Commercial Workers Trust Geographic Area Alaska Number of Participants Serviced 2,000 Announcement
Upper Peninsula Health Plan Advantage (HMO) (List of Covered Drugs)
Analgesics Opioid Analgesics, Long-acting fentanyl 100 mcg/hr patch td72 morphine sulfate 30 mg tablet er Opioid Analgesics, Short-acting fentanyl citrate 200 mcg lozenge hd hydrocodone/acetaminophen 5
Drug Classification and Pharmacologic Actions
Drug Classification and Pharmacologic Actions Learning Outcomes For major classes of drugs: Identify common drug names for each classification Describe actions- therapeutic uses Describe most common or
SYLLABUS OF PHARMACOLOGY FOR UNDERGRADUATE MEDICAL STUDENTS. GOAL: To inculcate a rational and scientific basis of therapeutics in a medical graduate
SYLLABUS OF PHARMACOLOGY FOR UNDERGRADUATE MEDICAL STUDENTS GOAL: To inculcate a rational and scientific basis of therapeutics in a medical graduate OBJECTIVES: (a) Knowledge and intellectual skills At
Nclex para la Enfermera Hispana
Nclex para la Enfermera Hispana Drug Classifications The following is a list of the major drug classifications, Memory tricks" are included where applicable (Retrieved from https://ncsbn.com) A Antianemics:
1 P a g e. Course Title. Course Number PN113
Date Course Title Credits Course Number Pharmacology & Medication Administration Pre-requisite (s) PN 112 Co-requisite (s) Hours 24 Hours Out of Class Work Assignment Hours PN113 10 Hours Place and Time
Department of Pharmacology, J. N. Medical College, AMU, Aligarh Syllabus for M.B.B.S. students in Pharmacology
Department of Pharmacology, J. N. Medical College, AMU, Aligarh Syllabus for M.B.B.S. students in Pharmacology Paper Title - Pharmacology Paper-I Course No.- MBBS-201 Max Marks -40 Unit A - General Pharmacology
Texas Vendor Drug Program. Formulary Drug Index File Layout. Layout effective: Jul. 2, 2018 Document update: Oct. 1, 2018
Texas Vendor Drug Program Formulary Drug Index File Layout Layout effective: Jul. 2, 2018 Document update: Oct. 1, 2018 The Vendor Drug Program provides a weekly update of resource data available for download
Supplementary Online Content
Supplementary Online Content Choudhry NK, Krumme AA, Ercole PM, et al. Effect of reminder devices on medication adherence: the REMIND randomized clinical trial. JAMA Int Med. Published online February
CMI Marketplace 2015 (List of Covered Drugs)
Analgesics Opioid Analgesics, Long-acting fentanyl 100 mcg/hr patch td72 fentanyl citrate 200 mcg lozenge hd morphine sulfate 30 mg tablet er oxymorphone hcl 7.5 mg tab er 12h Opioid Analgesics, Short-acting
ODESSA COLLEGE ASSOCIATE DEGREE NURSING PROGRAM SYLLABUS RNSG 1201 (Web Based) SUMMER I
ODESSA COLLEGE ASSOCIATE DEGREE NURSING PROGRAM SYLLABUS RNSG 1201 (Web Based) SUMMER I - 2012 COURSE TITLE: CREDIT: PLACEMENT: PREREQUISITES: COREQUISITES: PHARMACOLOGY TWO HOURS FIRST SEMESTER OF NURSING
Appropriate Use & Safety Edits
Appropriate Use & Safety Edits Envolve Pharmacy Solutions provides a variety of safety edits to promote the use of the right medication, in the right patient, at the right time. These edits are routinely
Texas Vendor Drug Program. Formulary Delimited File Layout. April 26, 2017
Texas Vendor Drug Program Formulary Delimited File Layout April 26, 2017 The Vendor Drug Program provides a weekly update of resource data available for download from txvendordrug.com/resources/downloads.
Course Title Systematic Pharmacology I
Course Code MED-308 Course Title Systematic Pharmacology I ECTS Credits 6 School Medical School Semester Spring (Semester 6) Prerequisites MED-303 Pharmacology Type of Course Field Language of Instruction
An Analysis of Exchange Plan Benefits for Certain Medicines
An Analysis of Exchange Plan Benefits for Certain Medicines June 2014 In Seven of the Selected Classes, Over One-Fifth of Silver Plans Require Coinsurance of 40 Percent or More for All Drugs in Class 60%
Pharmacology 260 Online Course Schedule Summer 2015
Pharmacology 260 Online Course Summer 201 The topics listed below do not necessarily correspond to a 1 - hour lecture period. You should cover the topics for each week at some time during that week. Readings
The Merck Index, Fourteenth Edition Therapeutic Category Index Terms
The Merck Index, Fourteenth Edition Therapeutic Category Index Terms Abortifacient/Interceptive ACE-Inhibitor see also Antihypertensive; Vasopeptidase Inhibitor Acidifier Adenosine Receptor Agonist α-adrenergic
SYLLABUS FOR PHARMACOLOGY AND TOXICOLOGY COURSES
SYLLABUS FOR PHARMACOLOGY AND TOXICOLOGY COURSES PCL 301: INTRODUCTION TO PHARMACOLOGY AND TOXICOLOGY (2C) Aim: To provide learners with an understanding of basic terms and principles of pharmacology with
Previous Codes. Code Definition Valid From Code Status. Notes P0: GENERAL ACTIVITY DESCRIPTORS
P0: GENERAL ACTIVITY DESCRIPTORS P001 Human activity 1965 Amended None Included veterinary up to 2014. From 2015 see P005. P002 Agricultural activity 1965 Existing None P003 Contact (general term) 1965
STANDARD COURSE SYLLABUS Pharmacology and Toxicology 4 th year Medical Faculty for academic year 2013/2014
STANDARD COURSE SYLLABUS Pharmacology and Toxicology 4 th year Medical Faculty for academic year 2013/2014 Description of subject matter Instructional program Name of subject: Pharmacology and Toxicology
Running head: PRESCRIPTIONS RECEIVED AT RETAIL PHARMACIES
Retail Pharmacy Prescription Analysis 1 Running head: PRESCRIPTIONS RECEIVED AT RETAIL PHARMACIES An Analysis of Prescription Claims for Medications from Retail Pharmacies in TRICARE Region 2 Naval Medical
Pharmacodynamics. Drugs usually elicit more than one effect. What the drug does to the body. How do drugs work? What do they do?
Pharmacology 203 Windward Community College Pharmacodynamics What the drug does to the body How do drugs work? What do they do? In this fact sheet, we will look at the fundamental mechanisms of drug action.
HES 128. Pharmacology and Dosage Calculations for Allied Health Occupations
HES 128 Pharmacology and Dosage Calculations for Allied Health Occupations Presented and Approved January 12, 2012 Effective Fall 2012-13 Pharmacology and Dosage Calculations: for Allied Health Occupations
HOUSTON COMMUNITY COLLEGE SYSTEM JOHN B. COLEMAN HEALTH SCIENCE CENTER ASSOCIATE DEGREE NURSING PROGRAM RNSG 1301 PHARMACOLOGY SYLLABUS SPRING 2012
HOUSTON COMMUNITY COLLEGE SYSTEM JOHN B. COLEMAN HEALTH SCIENCE CENTER ASSOCIATE DEGREE NURSING PROGRAM RNSG 1301 PHARMACOLOGY SYLLABUS SPRING 2012 CLASS Nbr 83113 1 HOUSTON COMMUNITY COLLEGE SYSTEM JOHN
Guideline of Pharmacology for International Student
Guideline of Pharmacology for International Student I Character and Objective of the Course 1. Character of the Course: Basic Medical Course. 2. Preparatory Course: Physiology, biochemistry, and pathophysiology.
Contents. 1. General Principles of Pharmacology Drugs Acting on Autonomic Nervous System Drugs Acting on Central Nervous System 62
Contents 1. General Principles of Pharmacology 1 Drug 1; History of Pharmacology 1; Route of Administration 3; Pharmacodynamics (Mode of Action of Drugs) 6; Drug Combinations 7; Factors Modifying Drug
Alabama Medicaid Pharmacy Override
Alabama Medicaid Pharmacy Override Therapeutic Duplication, Early Refill, Maximum Unit, Prescription Limit Switchover, Dispense as Written, Accumulation Edit, Maintenance Supply Opt Out, and Maximum Cost
JEFFERSON COLLEGE COURSE SYLLABUS VAT106. Applied Pharmacology. 3 Credit Hours. Prepared by: Robin Duntze, DVM
JEFFERSON COLLEGE COURSE SYLLABUS VAT106 Applied Pharmacology 3 Credit Hours Prepared by: Robin Duntze, DVM Revised by: Dana Nevois, MBA, BS, RVT April 6, 2017 Chris DeGeare, M.Ed., Division Chair, Business
Instructor Information
Department : Office Systems Technology Course Title : Pharmacology Section Name : HITT 1349 Start Date : 01/18/11 End Date : 05/07/11 Modality : WEB Instruction Credits : 3 Instructor Information Name
Modern Pharmacology with Clinical Applications
lift. Modern Pharmacology with Clinical Applications Fifth Edition Edited by Charles R. Craig, Ph.D. Professor of Pharmacology and Toxicology, West Virginia University School of Medicine, Morgantown, West
STATE UNIVERSITY OF NEW YORK COLLEGE OF TECHNOLOGY CANTON, NEW YORK. COURSE OUTLINE NURS 204 Pharmacology IV. Prepared By: John Conklin
STATE UNIVERSITY OF NEW YORK COLLEGE OF TECHNOLOGY CANTON, NEW YORK COURSE OUTLINE NURS 204 Pharmacology IV Prepared By: John Conklin SCHOOL OF SCIENCE, HEALTH AND CRIMINAL JUSTICE Nursing Department April
Department of Pharmacology VMMC and Safdarjung Hospital
4 th Semester Teaching Schedule, January, 2017, Batch-2015 03/01/2017, 03/01/2017, 10/01/2017, 10/01/2017, 10/01/2017, 17/01/2017, 17/01/2017, 17/01/2017, 24/01/2017, 24/01/2017, 24/01/2017, 31/01/2017,
Chapter 12. Learning Objectives. Learning Objectives (Cont d) 9/10/2012. Drug and Chemical Classes
Chapter 12 Drug and Chemical Classes Learning Objectives List, describe drugs paramedic may administer according to local protocol Integrate pathophysiologic principles of pharmacology with patient assessment
Pharmacy Technician Course
Pharmacy Technician Course VERSION HISTORY SECTION 1: History and Scope of the Pharmacy Technician Scope of the Pharmacy Technician Section 1 Quiz Check Your Knowledge Section 1 Quiz Answers SECTION 2:
HOUSTON COMMUNITY COLLEGE SYSTEM JOHN B. COLEMAN HEALTH SCIENCE CENTER ASSOCIATE DEGREE NURSING PROGRAM RNSG 1301 PHARMACOLOGY AND THE NURSING PROCESS
HOUSTON COMMUNITY COLLEGE SYSTEM JOHN B. COLEMAN HEALTH SCIENCE CENTER ASSOCIATE DEGREE NURSING PROGRAM RNSG 1301 PHARMACOLOGY AND THE NURSING PROCESS SYLLABUS (CRN 83388 & 83119) SPRING 2012 1 HOUSTON
CHAPTER ONE: EXECUTIVE SUMMARY
CHAPTER ONE: EXECUTIVE SUMMARY Introduction Scope and Methodology Total Size and Growth of the Market Issues and Trends Affecting Market Leading Competitors CHAPTER TWO: INTRODUCTION AND INDUSTRY TRENDS
KS Council of PN Educators - PN PN Program. KSPN Nursing Care of Adults II Course Syllabus
KS Council of PN Educators - PN PN Program KSPN Nursing Care of Adults II Course Syllabus Course Information: Course Number and Title: KSPN 010 - KSPN Nursing Care of Adults II Total Credit/Contact Hours:
Herbal actions the language of herbalists
Herbal actions the language of herbalists Artist Bracket fungus immune modulating, anti-inflammatory If you ve ever read any herbal books you will often come across a wide range of unusual terms that on
About the PCTB Examination Assisting the Pharmacist in Serving Patients p. 1 Filling the Medication Order p. 3 Receiving the Medication Order p.
Preface p. ix About the PCTB Examination p. xii Assisting the Pharmacist in Serving Patients p. 1 Filling the Medication Order p. 3 Receiving the Medication Order p. 4 The Retail Medication Order p. 6
SPECIFIC AIMS. IV year (1st 2nd semester) A.Y
IV year (1st 2nd semester) A.Y. 2017-2018 BARBACCIA M.L. COORINATOR Scientific Field PHARMACOLOGY TUTOR ECTS BIO/14 Pharmacology 1 Barbaccia Maria Luisa 3 BIO/14 Pharmacology 1 Battaini Fiorenzo Maria
Condition/Procedure Measure Compliance Criteria Reference Attribution Method
Premium Specialty: Cardiology Credentialed Specialties include: Cardiac Diagnostic, Cardiology, Cardiovascular Disease, Clinical Cardiac Electrophysiology, and Interventional Cardiology This document is
Composition Each ml of Ventol solution for inhalation contains 5 mg Salbutamol (as sulphate).
VENTOL Composition Each ml of Ventol solution for inhalation contains 5 mg Salbutamol (as sulphate). Respiratory Solution Action Salbutamol is a short-acting, relatively selective beta2-adrenoceptor agonist.
Table A1: Fifty Most Often Repeated Oral Drug Product Shortages (35 ingredients), Canada,
1 Appendix Commentary 515 Appendix: Assessing Canada s Drug Shortage Problem Table A1: Fifty Most Often Repeated Oral Drug Product Shortages (35 ingredients), Canada, 2013 16 Drug Name Dosage Therapeutic
Herbal Properties Glossary
Herbal Properties Glossary Adaptogen A non-toxic compound that increases resistance to physical, chemical, and emotional stresses. These compounds seem only to be activated when one is under stress. They
Added, Removed or Changed. Added, Removed or Changed
One mission: you s March 8, 2018 Blue Cross of Idaho reviews its formularies (covered drug lists) periodically to allow members access to new drugs and to provide safe, cost effective options for your
Medicinal products of Kusum Pharm Ltd. registered in Ukraine - 1 -
- 1-1. Abrol tablets 30, No. 20 (10 2) in 1 tablet contains ambroxol hydrochloride 30 UA/9928/01/01 2. Abrol syrup, 15 /5 ml, 100 ml in a bottle 5 ml of syrup contain ambroxol hydrochloride15 Medicines
Kentucky Department for Medicaid Services. Drug Review Options
Kentucky Department for Medicaid Services Drug Review Options The following chart lists the agenda items scheduled and the options submitted for review at the March 18, 2010 meeting of the Pharmacy and
Alabama Medicaid Preferred Drug and Prior Authorization Program
Alabama Medicaid Preferred Drug and Prior Authorization Program Prior Authorization (PA) Criteria Instructions This document contains detailed instructions on completing the Medicaid Prior Authorization
BIO 116 Practice Assignment 1 The Endocrine System and Blood This is not a required assignment but it is recommended.
BIO 116 Practice Assignment 1 The Endocrine System and Blood This is not a required assignment but it is recommended. 1. Match the following glands of the endocrine system with the appropriate label 1.
Creates a loss of Provide Used in EMS for sedation for cardioversion, RSI, and chemical restraint, Versed
1 Chapter 6, Part 2 General Principles of Pharmacology 2 Drug Classifications There are numerous drug classifications in the medical field Most EMS medications are: medications medications Respiratory
UNIVERSITY OF ZAGREB SCHOOL OF MEDICINE. Plan of the course. Pharmacology. Academic year 2017/2018. prof. dr. sc. Melita Šalković-Petrišić
UNIVERSITY OF ZAGREB SCHOOL OF MEDICINE Plan of the course Pharmacology Academic year 2017/2018 I. COURSE AIMS To give the students the understanding of pharmacokinetics and pharmacodynamics principles
Covered California Formulary Analysis of Top 100 Drugs and Select Classes Prepared for the California HealthCare Foundation Avalere.
Covered California Formulary Analysis of Top 100 Drugs and Select Classes Prepared for the California HealthCare Foundation 2015 Avalere.com About the Researchers ABOUT THE CALIFORNIA HEALTHCARE FOUNDATION
SUBJECT TEACHING GUIDE
SUBJECT TEACHING GUIDE G1371 - Fundamental Pharmacology Degree in Medicine Academic year 2018-2019 1. IDENTIFYING DATA Degree Degree in Medicine Type and Year Compulsory. Year 3 Faculty Discipline Course
Primary Diagnosis YES NO ICD - Code Cancer Cognitive impairment Cardiac Respiratory Neurological Musculoskeletal Respiratory Other
Chart review date: / / Reviewer: Centre Name: Hospital Home RACF DOB: / / AGE: GENDER: Male Female Admission Date: / / Death Date: / / 1. DIAGNOSIS Primary Diagnosis YES NO ICD - Code Cancer Cognitive
PHARMACOLOGY MILESTONES:
2017-18 Pharmacology Integrated Curriculum: Goal: Promote the learning of pharmacology in a clinical context Pharmacology content will focus on that which is clinically relevant. The Pharmacology theme
Pharmacology for CHEMISTS
Pharmacology for CHEMISTS JOSEPH G. CANNON ACS Professional Reference Book AMERICAN CHEMICAL SOCIETY OXFORD UNIVERSITY PRESS Washington D.C. New York Oxford 1999 CONTENTS I Chemical and Biological Bases
Exam Key. NROSCI/BIOSC 1070 and MSNBIO 2070 Final Exam December 19, 2015 Total POINTS: % of grade in class
NROSCI/BIOSC 1070 and MSNBIO 2070 Final Exam December 19, 2015 Total POINTS: 100 20% of grade in class 1) Zollinger-Ellison syndrome results from a gastrin-secreting tumor, producing increased numbers
Pharmacology - Problem Drill 11: Vasoactive Agents
Pharmacology - Problem Drill 11: Vasoactive Agents Question No. 1 of 10 1. Vascular smooth muscle contraction is triggered by a rise in. Question #01 (A) Luminal calcium (B) Extracellular calcium (C) Intracellular
Heart Failure (HF) Treatment
Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and
Respiratory Pharmacology. Manuel Otero Lopez Department of Anaesthetics and Intensive Care Hôpital Européen Georges Pompidou, Paris, France
Respiratory Pharmacology Manuel Otero Lopez Department of Anaesthetics and Intensive Care Hôpital Européen Georges Pompidou, Paris, France Programme Bronchomotor tone Drugs and factors influencing airway
Drugs Categories. 4. Which suffix do erectile dysfunction generic drug names often end with?
CATEGORIES: QUIZ 1 Drugs Categories 1. What drug subcategory often ends with the suffix -afil? a. Alpha blockers b. Antianxiety c. ACE inhibitors d. Antivirals e. Erectile dysfunction 2. What drug subcategory
Primary Healthcare Panel Reports DATA DICTIONARY
Primary Healthcare Panel Reports DATA DICTIONARY DOCUMENT COPYRIGHT The Health Quality Council of Alberta holds copyright and intellectual property rights of this document. This document is licensed under
Integrated Cardiopulmonary Pharmacology Third Edition
Integrated Cardiopulmonary Pharmacology Third Edition Chapter 3 Pharmacology of the Autonomic Nervous System Multimedia Directory Slide 19 Slide 37 Slide 38 Slide 39 Slide 40 Slide 41 Slide 42 Slide 43
Anatomical Therapeutic Chemical Classification (ATC) & And Defined Daily Dose (DDD) Principles for classifying and quantifying drug use
Anatomical Therapeutic Chemical Classification (ATC) & And Defined Daily Dose (DDD) Principles for classifying and quantifying drug use Margaret Oluka Course outline/objectives 1. Introduction: drug classification
Clinical Pharmacology and Drug Therapy
Oxford Textbook of Clinical Pharmacology and Drug Therapy THIRD EDITION D. G. Grahame-Smith CBE, MBBS, PhD, FRCP Emeritus Professor of Clinical Pharmacology, University of Oxford and J.K. Aronson MBChB,
A SLP s Guide to Medication Therapy and Management. Sarah Luby, PharmD, BCPS KSHA 2017
A SLP s Guide to Medication Therapy and Management Sarah Luby, PharmD, BCPS KSHA 2017 Objectives Identify the appropriate route of administration for medications and proper formulations for use Understand
Salicylates: Interactions 10/14/2009. Salicylates DRUGS USED IN THE MANAGEMENT OF MUSCULOSKELETAL DISORDERS. Chapters 17, 18, 34 & Pages 577 &
DRUGS USED IN THE MANAGEMENT OF MUSCULOSKELETAL DISORDERS Chapters 17, 18, 34 & Pages 577 & 579-586 Salicylates aspirin Have analgesic, antipyretic, and anti-inflammatory effects. Inhibits the production
Chapter 10 Worksheet Blood Pressure and Antithrombotic Agents
Complete the following. 1. A layer of cells lines each vessel in the vascular system. This layer is a passive barrier that keeps cells and proteins from going into tissues; it also contains substances
Controlled Substance Monitoring and Drugs of Abuse Testing Determination
CPT s: 80305 Drug test(s), presumptive, any number of drug classes, any number of devices or procedures (eg, immunoassay); capable of being read by direct optical observation only (eg, dipsticks, cups,
1. Foods containing tyramine should not be eaten by patients taking: a. Fluvoxamine b. Imipramine c. Maprotiline d. Nefazodone e.
Various Pharmacology Questions 1. Foods containing tyramine should not be eaten by patients taking: a. Fluvoxamine b. Imipramine c. Maprotiline d. Nefazodone e. Tranylcypromine 2. Which is true of Selective
COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK
COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK Robert L Alesiani, PharmD, CGP Chief Pharmacotherapy Officer CareKinesis, Inc. (a Tabula Rasa Healthcare Company) 2 3 4 5 Pharmacogenomics
CATEGORIES: QUIZ 2. Drugs Categories. 1. What drug subcategory often ends with the suffix -asone?
CATEGORIES: QUIZ 2 Drugs Categories 1. What drug subcategory often ends with the suffix -asone? a. Alpha blockers b. Corticosteroids c. Calcium channel blockers d. Beta blockers e. ACE inhibitors 2. What
Major intra and extracellular ions Lec: 1
Major intra and extracellular ions Lec: 1 The body fluids are solutions of inorganic and organic solutes. The concentration balance of the various components is maintained in order for the cell and tissue
Section 3, Lecture 2
59-291 Section 3, Lecture 2 Diuretics: -increase in Na + excretion (naturesis) Thiazide and Related diuretics -decreased PVR due to decreases muscle contraction -an economical and effective treatment -protect
The adrenergic drugs affect receptors that are stimulated by norepinephrine or epinephrine. Some adrenergic drugs act directly on the adrenergic
Adrenergic drugs The adrenergic drugs affect receptors that are stimulated by norepinephrine or epinephrine. Some adrenergic drugs act directly on the adrenergic receptor (adrenoceptor) by activating it
Medicine purposes and side effects
Medicine purposes and side effects Ace inhibitors Purpose: Relaxes blood vessels and decreases blood volume, which lowers blood pressure and decreases oxygen demand from the heart Side effects: Low blood
Chapter 19 The Urinary System Fluid and Electrolyte Balance
Chapter 19 The Urinary System Fluid and Electrolyte Balance Chapter Outline The Concept of Balance Water Balance Sodium Balance Potassium Balance Calcium Balance Interactions between Fluid and Electrolyte
Beta 1 Beta blockers A - Propranolol,
Pharma Lecture 3 Beta blockers that we are most interested in are the ones that target Beta 1 receptors. Beta blockers A - Propranolol, it s a non-selective competitive antagonist of beta 1 and beta 2
HOW TO USE Clinical Drug Therapy
HOW TO USE Clinical Drug Therapy Drugs at a Glance tables give students characteristics as well as routes and dosage ranges in an easy-to-read format. Prototype drugs are highlighted in the tables and
DRUG NAMING AND CLASSES
DRUG NAMING AND CLASSES PROPRIETARY OR TRADEMARK NAME When a drug shows promise of being effective, the drug the sponsor will apply for a proprietary or trademark name. When a drug patent expires, other
distinguish between structural isomers (but not necessarily stereoisomers), including, but not
CPT s: 80305 Drug test(s), presumptive, any number of drug classes, any number of devices or procedures (eg, immunoassay); capable of being read by direct optical observation only (eg, dipsticks, cups,
Chapter 26 Fluid, Electrolyte, and Acid- Base Balance
Chapter 26 Fluid, Electrolyte, and Acid- Base Balance 1 Body Water Content Infants: 73% or more water (low body fat, low bone mass) Adult males: ~60% water Adult females: ~50% water (higher fat content,
Autonomic Nervous System. Introduction
Autonomic Nervous System Introduction 1 The nervous system is divided into: 1- the central nervous system (CNS; the brain and spinal cord) 2- the peripheral nervous system (PNS; neuronal tissues outside
PHARMACOLOGY Academic Year
PHARMACOLOGY Academic Year 2016-2017 Prof. Jean François DESAPHY Pharmacology Part I (4 CFU, 48 hours) I semester General concepts Pharmacodynamics Pharmacokinetics Toxicology notions - Adverse drug reactions
Part 2: How Your Brain and Nervous System Work
Part 2: How Your Brain and Nervous System Work with Dr. Ritamarie Loscalzo Medical Disclaimer: The information in this presentation is not intended to replace a one onone relationship with a qualified